The Technical Analyst

Waldencast plc [WALDU]

Exchange: NASDAQ Capital Market Sector: Technology Industry: Software - Application

Waldencast plc Price, Forecast, Insider, Ratings, Fundamentals & Signals

2.66% $9.07

/ 27 jul 2022 @ 12:05

FIND ALL MARKETS FIND ALL STOCKS LISTED @ NASDAQ Capital Market Live Signal Oslo Live Signal Nasdaq Live Signal Crypto

Waldencast plc: Main Fundamentals PE comparison

RATING 2022-08-05
B+
Neutral

RATINGS
Rating CashFlow:	Strong Buy
Return On Equity:	Neutral
Return On Asset:	Neutral
DE:	Sell
P/E:	Strong Buy
Price To Book:	Strong Sell

QUARTER GROWTHS
	3/22	3/22	4/22	1/23	2/23	3/23
Revenue	n/a	n/a			n/a	n/a
Gr.Profit	n/a	n/a			n/a	n/a
Ebit					n/a	n/a
Asset			n/a		n/a	n/a
Debt			n/a		n/a	n/a

PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -38.74 \| sector: PE 0

PE RATIO: COMPANY / INDUSTRY
0x
Company: PE -38.74 \| industry: PE 0

DISCOUNTED CASH FLOW VALUE
N/A
N/A

Expected Trading Range (DAY)
$ 8.98 - 9.15 ( +/- 0.93%)
ATR Model: 14 days

Forecast: 01:40 - $10.00

Live Trading Signals (every 1 min)

SCORE
10.00
Buy

Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022

Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD

Volume Signals
Price	$9.07 (2.66% )
Volume	0.0026 mill
Avg. Vol.	0 mill
% of Avg. Vol	0 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Waldencast plc

Last 12 Months

RSI

Last 10 Buy & Sell Signals For WALDU

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date	Signal	@	Closed	%

WALDU

Waldencast Acquisition Corp. a skin care company, provides advanced skin care treatments. Its products are designed to help minimize the appearance of premature skin aging, skin damage, hyperpigmentation, acne, and sun damage primarily available through dermatologists, plastic surgeons, medical spas, and other skin care professionals. Its portfolio includes Obagi Medical that provides transformational skin care products formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines, and wrinkles and to protect and enhance skin tone and texture; and Obagi Clinical that offers skin care products designed to prevent the early signs of skin aging. The company was founded in 1988 and is based in White Plains, New York.

Last 10 Buy Signals

Date	Signal	@
MPLUSD	Apr 18 - 23:56	15.69
DXUSD	Apr 18 - 23:30	106.01
NGUSD	Apr 18 - 23:33	$1.768
PAXGUSD	Apr 18 - 23:32	2 417.36
HOUSD	Apr 18 - 23:18	$2.60
RBUSD	Apr 18 - 23:18	$2.75
PLUSD	Apr 18 - 23:18	$952.20
HGUSD	Apr 18 - 23:19	$4.41
CLUSD	Apr 18 - 23:17	$85.00
SILUSD	Apr 18 - 23:14	28.33

Latest Press Releases

2021-05-07 16:10:00 - Press Release

Waldencast Acquisition Corp. Announces The Separate Trading Of Its Class A Ordinary Shares And Redeemable Warrants Commencing May 10, 2021

New york--(business wire)--waldencast acquisition corp. (nasdaq: waldu) (the “company”) today announced that, commencing may 10, 2021, holders of the units sold in the company's initial public offering of 34,500,000 units completed on march 18, 2021, may elect to separately trade the class a ordinary shares and redeemable warrants included in the units. those units not separated will continue to trade on the nasdaq stock market llc (the “nasdaq”) under the symbol “waldu,” and the class a ordina

Latest News

2021-05-07 16:10:00 - Business Wire

Waldencast Acquisition Corp. Announces the Separate Trading of Its Class A Ordinary Shares and Redeemable Warrants Commencing May 10, 2021

NEW YORK--(BUSINESS WIRE)--Waldencast Acquisition Corp. (NASDAQ: WALDU) (the “Company”) today announced that, commencing May 10, 2021, holders of the units sold in the Company's initial public offering of 34,500,000 units completed on March 18, 2021, may elect to separately trade the Class A ordinary shares and redeemable warrants included in the units. Those units not separated will continue to trade on The Nasdaq Stock Market LLC (the “Nasdaq”) under the symbol “WALDU,” and the Class A ordina

Full Story

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.